tiprankstipranks
Trending News
More News >
Sonoma Pharmaceuticals (SNOA)
NASDAQ:SNOA
US Market

Sonoma Pharmaceuticals (SNOA) Income Statement

Compare
351 Followers

Sonoma Pharmaceuticals Income Statement

Last quarter (Q2 2026), Sonoma Pharmaceuticals's total revenue was $5.60M, an increase of 56.58% from the same quarter last year. In Q2, Sonoma Pharmaceuticals's net income was $-534.00K. See Sonoma Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 14.29M$ 12.73M$ 13.27M$ 12.63M$ 18.63M
Gross Profit
$ 5.46M$ 4.75M$ 4.48M$ 3.99M$ 6.56M
Operating Expenses
$ 9.18M$ 9.45M$ 9.05M$ 9.88M$ 10.01M
Depreciation and Amortization
$ 138.00K$ 176.00K$ 125.00K$ 186.00K$ 227.00K
EBITDA
$ -3.57M$ -4.53M$ -4.45M$ -5.70M$ -3.22M
Operating Income
$ -3.71M$ -4.70M$ -4.57M$ -5.89M$ -3.45M
Other Income/Expenses
$ 803.00K$ -330.00K$ -614.00K$ 469.00K$ -453.00K
Pretax Income
$ -2.91M$ -5.03M$ -5.18M$ -5.42M$ -3.90M
Net Income
$ -3.46M$ -4.83M$ -5.15M$ -5.09M$ -3.95M
Per Share Metrics
Basic EPS
$ -2.79$ -5.32$ -15.18$ -19.17$ -23.65
Diluted EPS
$ -2.79$ -5.32$ -15.18$ -19.17$ -23.65
Weighted Average Shares Outstanding
1.24M 909.00K 339.40K 265.30K 199.60K
Weighted Average Shares Outstanding (Diluted)
1.24M 909.00K 339.40K 265.30K 199.60K
Currency in USD

Sonoma Pharmaceuticals Earnings and Revenue History